# Dimitri Panayotopoulos

> Dimitri Panayotopoulos is a funding round investor at The Boston Consulting Group backing Biopharma. See 1 investments, check sizes, portfolio. Updated Aug…

- Type: Angel Investor
- Fund: [The Boston Consulting Group](https://shizune.co/investors/profile/boston-consulting-group)
- Location: Cincinnati, United States
- Total investments: 1
- Last investment: Jun 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://nl.linkedin.com/in/dimitri-panayotopoulos-3b27b289

Dimitri Panayotopoulos is a funding round investor at The Boston Consulting Group in Cincinnati focused on Biopharma and Health Care. Dimitri Panayotopoulos has been a non-executive member of Logitech's board of directors since December 2014 and serves on Logitech’s Compensation Committee.Dimitri Panayotopoulos is a senior advisor at The Boston Consulting Group, a global management consulting firm. Prior to joining The Boston Consulting Group in 2014, DimitriPanayotopoulos served with The Procter & Gamble Company (P&G), a consumer brand company, for over thirty years. At P&G, he held a variety of senior roles in regions across the world including vice chairman and advisor to the chairman & CEO from 2013 to 2014, vice chairman of Global Business Units from 2011 to 2013 and vice chairman of Global Household Care Group from 2007 to 2011. Dimitri Panayotopoulos’ previous roles at P&G included various executive, managerial and other positions in Europe (including Switzerland), Africa, China, Egypt and the Far East.At P&G, he held a variety of senior roles in regions across the world including vice chairman and advisor to the chairman & CEO from 2013 to 2014, vice chairman of Global Business Units from 2011 to 2013 and vice chairman of Global Household Care Group from 2007 to 2011. Dimitri Panayotopoulos’ previous roles at P&G included various executive, managerial and other positions in Europe (including Switzerland), Africa, China, Egypt and the Far East. serves on the board of directors of British American Tobacco p.l.c.Panayotopoulos holds a B.A. degree from Sussex University, U.K.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Legacy Healthcare | Legacy Healthcare is developping safer drugs for the treatment of autoimmune and inflammatory diseases in fragile patients |  |  | Jun 01, 2020 |  |

1 of 1 investments shown.

## About The Boston Consulting Group

VC Fund · Boston, United States

The Boston Consulting Group is a global management consulting firm and an advisor on business strategy. The firm partners with clients in all sectors and regions to identify their opportunities, address their critical challenges, and transform their businesses.The Boston Consulting Group was founded in July 1963 by Bruce Henderson and isheadquartered in Boston, Massachusetts. It has 82 offices in 46 countries.

5 contacts available at The Boston Consulting Group.

| Name | Title | Profile |
| --- | --- | --- |
| Aliza Knox | Senior Advisor | https://shizune.co/investors/profile/aliza-knox |
| Christopher Freese | Senior Partner & Managing Director | https://shizune.co/investors/profile/christopher-freese |
| Dimitri Panayotopoulos | Senior Member of the Board of Advisors | https://shizune.co/investors/profile/dimitri-panayotopoulos |
| Elizabeth Kopp | Business Management Director, San Diego | https://shizune.co/investors/profile/elizabeth-kopp |
| Evan Silberhorn | Principal and General Manager | https://shizune.co/investors/profile/evan-silberhorn |

## Similar investors

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

## FAQ

### What does Dimitri Panayotopoulos invest in?

Dimitri Panayotopoulos invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Funding Round stage. Most of the 1 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Dimitri Panayotopoulos last invest?

The most recent investment recorded for Dimitri Panayotopoulos closed in Jun 2020. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co